Haleon plc

Haleon plc, a UK-based pharmaceutical preparation manufacturer, is committed to reducing its carbon emissions. In 2023, Haleon plc's total reported carbon emissions were approximately 2.9 billion kg CO2e. This included around 60 million kg CO2e from Scope 1 emissions, a market-based total of 7 million kg CO2e from Scope 2 emissions, and approximately 2.7 billion kg CO2e from Scope 3 emissions.

Haleon plc has set ambitious climate targets. The company aims to reduce its net Scope 1 and 2 carbon emissions by 100% by 2030, compared to a 2020 baseline. More specifically, Haleon plc commits to an absolute reduction of 95% for Scope 1 and 2 GHG emissions by FY2030 from a FY2020 base year. For Scope 3 emissions, Haleon plc aims to reduce emissions from source to sale by 42% by 2030, using a 2022 baseline. These near-term targets are classified as consistent with a 1.5°C warming scenario by the Science Based Targets initiative (SBTi), to which Haleon plc is a signatory. The company has also committed to achieving net-zero carbon emissions from source to sale by 2040, aligning with guidance from The Climate Pledge and Race to Zero initiatives. Furthermore, Haleon plc aims to reduce its Scope 1 and Scope 2 emissions to near zero by 2025.